⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TPST News
Tempest Therapeutics, Inc. Common Stock
Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds
globenewswire.com
TPST
Form 8-K
sec.gov
TPST
Form 8-K
sec.gov
TPST
Form 8-K
sec.gov
TPST
Tempest Reports First Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
TPST
Form 8-K
sec.gov
TPST
Tempest Presents Clinical Update at ISCT 2026 Annual Meeting
globenewswire.com
TPST
Tempest to Advance Dual-Targeting CAR-T Platform with Clinical Update at ISCT 2026 Annual Meeting
globenewswire.com
TPST
Tempest Announces Key Manufacturing Milestone for TPST-2003 Dual-Targeting CD19/BCMA CAR-T
globenewswire.com
TPST
Tempest Appoints Andrew Fang, Ph.D., as Head of Business Development to Advance Strategic Partnerships and Global Licensing Efforts
globenewswire.com
TPST